US 8143226
Tyrosine kinase receptor antagonists and methods of treatment for breast cancer
granted A61KA61K31/404A61K31/70
Quick answer
US patent 8143226 (Tyrosine kinase receptor antagonists and methods of treatment for breast cancer) held by The Regents of the University of California expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/404, A61K31/70, A61P, A61P35/00